XEOS AURA 10 improves breast cancer margin detection, but is it ready for routine surgery?
Discover how XEOS AURA 10 could improve breast cancer margin detection while cost, workflow demands and false positives limit wider adoption.
Discover how XEOS AURA 10 could improve breast cancer margin detection while cost, workflow demands and false positives limit wider adoption.
Breast cancer surgery still struggles with missed margins. Cairn Surgical’s trial raises a sharper question for wire localization.
Breast cancer care needs sharper radiation decisions. PreludeDx’s AidaBREAST now faces the harder test of validation, adoption and access.